EDIT

Editas Medicine, Inc.

4 transactions on file, per SEC Form 4 filings.

Ory Daniel Scott

EVP, Chief Medical Officer · 2026-09-08

Award

$2.9M

Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER · 2026-09-03

Sold

$2K

Parison Amy

SVP, Chief Financial Officer · 2026-09-03

Sold

$1K

O'Neill Gilmore Neil

CEO · 2026-09-03

Sold

$16K

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is EDIT actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.